✦ LIBER ✦

Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma

✍ Scribed by Abraham, R; Chen, C; Tsang, R; Simpson, D; Murray, C; Davidson, M; Meharchand, J; Sutton, D M; Crump, R M; Keating, A

Book ID: 110012297
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 75 KB
Volume: 24
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1702060

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose idarubicin, cyclophosphamide a

High-dose idarubicin, cyclophosphamide and melphalan as conditioning for autologous stem cell transplantation increases treatment-related mortality in patients with multiple myeloma: results of a randomised study

✍ R. Fenk; P. Schneider; M. Kropff; A. N. Huenerlituerkoglu; U. Steidl; C. Aul; B. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Bortezomib Plus Dexamethasone Is Superio

Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial

✍ Harousseau, J.-L.; Attal, M.; Avet-Loiseau, H.; Marit, G.; Caillot, D.; Mohty, M 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 165 KB